GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Total Assets

Sonoscape Medical (SZSE:300633) Total Assets : ¥4,044 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Total Assets?

Sonoscape Medical's Total Assets for the quarter that ended in Mar. 2024 was ¥4,044 Mil.

During the past 12 months, Sonoscape Medical's average Total Assets Growth Rate was 11.80% per year. During the past 3 years, the average Total Assets Growth Rate was 11.90% per year. During the past 5 years, the average Total Assets Growth Rate was 6.50% per year. During the past 10 years, the average Total Assets Growth Rate was 14.00% per year.

During the past 12 years, Sonoscape Medical's highest 3-Year average Total Assets Growth Rate was 27.10%. The lowest was 3.10%. And the median was 12.10%.

Total Assets is connected with ROA %. Sonoscape Medical's annualized ROA % for the quarter that ended in Mar. 2024 was 10.26%. Total Assets is also linked to Revenue through Asset Turnover. Sonoscape Medical's Asset Turnover for the quarter that ended in Mar. 2024 was 0.12.


Sonoscape Medical Total Assets Historical Data

The historical data trend for Sonoscape Medical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Total Assets Chart

Sonoscape Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,414.38 2,286.65 3,020.36 3,544.28 3,771.42

Sonoscape Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,692.46 3,692.74 3,713.42 3,771.42 4,043.65

Sonoscape Medical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sonoscape Medical's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=3145.954+625.463
=3,771

Sonoscape Medical's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=3256.348+787.306
=4,044

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sonoscape Medical  (SZSE:300633) Total Assets Explanation

Total Assets is connected with ROA %.

Sonoscape Medical's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=400.764/( (3771.417+4043.654)/ 2 )
=400.764/3907.5355
=10.26 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sonoscape Medical's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=479.334/( (3771.417+4043.654)/ 2 )
=479.334/3907.5355
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sonoscape Medical Total Assets Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical (SZSE:300633) Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
Executives
Zhou Wen Ping Directors, executives
Huang Yi Bo Directors, executives
Li Hao Directors, executives
Chen Zhi Qiang Director
Wu Kun Xiang Directors, executives
Liu Ying Fang Director

Sonoscape Medical (SZSE:300633) Headlines

No Headlines